IB
Iovance Biotherapeutics Inc
🇩🇪XSTU.2LBGermanyHealthcare
€8.36EURup +0.35 (+4.37%)ClosedEnd of day11:26 PM
Price€8.36+0.35 (+4.37%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US4622601007
- CUSIP
- Not reported
Company
- Employees
- 975
- Headquarters
- San Carlos, United States
- Website
- https://www.iovance.com
- CEO
- Dr. Frederick G. Vogt Esq., J.D., Ph.D.
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- Not reported
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $324.97M+34.55%up year on year
- Net income
- -$289.52M+25.75%up year on year
- Gross margin
- 116.3%+464.57%up year on year
- Free cash flow
- -$296.4M+8.39%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.